Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Clinical and histopathological profile of a patient with localized lepromatous leprosy

Jose J, Das L, Singh P, et al. Leprosy review. 2019; 90 (4) : 476– 481.
Download PDF
Publication

Bullous erythema nodosum leprosum: a rare case series

Pradhan S, Rout A, Sirka C, et al. Leprosy review. 2019; 90 (4) : 469– 475.
Download PDF
Publication

Successful treatment of rifampicin resistant case of leprosy by WHO recommended ofloxacin and minocycline regimen

Lavania M, Darlong J, Reddy A, et al. Leprosy review. 2019; 90 (4) : 456–459.
Download PDF
Publication

Melioidosis complicating lepromatous leprosy with type 2 lepra reaction: A rare case report from India

Pradhan S, Rout A, Sirka C, et al. Leprosy review. 2019; 90 (4) : 450–455.
Download PDF
Publication

Community stigma and desired social distance towards people affected by leprosy in Chandauli District, India

Ballering V B, Peters R, Waltz M, et al. Leprosy review. 2019;
Download PDF
Publication

Case-control study measuring the association between HLA-B*13:01 and dapsone hypersensitivity syndrome in Indian patients

Chiramel M, George R, Daniel D, et al. Leprosy review. 2019; 90 (4) : 371–377.
Download PDF
Publication

Ultrasonography versus clinical examination in detecting leprosy neuropathy

Kumaran M, Thapa M, Narang T, et al. Leprosy review. 2019; 90 (4) : 364– 370.
Download PDF
Publication

Molecular characterization of environmental mycobacterial species from leprosy endemic tribal regions of North Purulia District, West Bengal.

Singh V, Turankar R, Goel A. International journal of mycobacteriology. 2019; 8 (4) : 381-389.
Download PDF
Publication

Isolation of Mycobacterium lepromatosis and Development of Molecular Diagnostic Assays to Distinguish M. leprae and M. lepromatosis.

Sharma R, Singh P, McCoy R, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2019;
Download PDF
Publication

Raman spectroscopy reveals distinct differences between two closely related bacterial strains, Mycobacterium indicus pranii and Mycobacterium intracellulare.

Verma T, Podder S, Mehta M, et al. Analytical and bioanalytical chemistry. 2019;

Pagination

  • Previous page ‹‹
  • Page 81
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD